CONCORD DRUGS
Back to Cashflow Statement
|
CONCORD DRUGS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.43 Cr | ₹0.28 Cr | ₹0.62 Cr | ₹1.68 Cr |
What is the latest Cash Flow from Financing Activities ratio of CONCORD DRUGS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1.43 Cr |
| Mar2024 | ₹0.28 Cr |
| Mar2023 | ₹0.62 Cr |
| Mar2022 | ₹1.68 Cr |
How is Cash Flow from Financing Activities of CONCORD DRUGS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.43 Cr | Negative | |
| Mar2024 | ₹0.28 Cr | -54.65 | |
| Mar2023 | ₹0.62 Cr | -62.84 | |
| Mar2022 | ₹1.68 Cr | - | |
Compare Cash Flow from Financing Activities of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹102.2 Cr | 0.7% | -6.1% | 143.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | 0.7% |
-6.1% |
143.8% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses